These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10986563)

  • 1. Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients.
    Molinier-Frenkel V; Le Boulaire C; Le Gal FA; Gahéry-Segard H; Tursz T; Guillet JG; Farace F
    Hum Gene Ther; 2000 Sep; 11(13):1911-20. PubMed ID: 10986563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients.
    Tursz T; Cesne AL; Baldeyrou P; Gautier E; Opolon P; Schatz C; Pavirani A; Courtney M; Lamy D; Ragot T; Saulnier P; Andremont A; Monier R; Perricaudet M; Le Chevalier T
    J Natl Cancer Inst; 1996 Dec; 88(24):1857-63. PubMed ID: 8961977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cellular immune responses in rhesus monkeys subjected to adenovirus-mediated gene transfer into the cervix.
    Sarkar AK; Mitchell MF; Hamada K; Buchl SJ; Satterfield WC; Schapiro SJ; Keeling ME; Sastry KJ
    Cancer Gene Ther; 1999; 6(3):220-7. PubMed ID: 10359207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus.
    Krebs P; Scandella E; Odermatt B; Ludewig B
    J Immunol; 2005 Apr; 174(8):4559-66. PubMed ID: 15814677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53).
    Yen N; Ioannides CG; Xu K; Swisher SG; Lawrence DD; Kemp BL; El-Naggar AK; Cristiano RJ; Fang B; Glisson BS; Hong WK; Khuri FR; Kurie JM; Lee JJ; Lee JS; Merritt JA; Mukhopadhyay T; Nesbitt JC; Nguyen D; Perez-Soler R; Pisters KM; Putnam JB; Schrump DS; Shin DM; Walsh GL; Roth JA
    Cancer Gene Ther; 2000 Apr; 7(4):530-6. PubMed ID: 10811470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term transgene expression within the anterior pituitary gland in situ: impact on circulating hormone levels, cellular and antibody-mediated immune responses.
    Southgate TD; Stone D; Williams JC; Lowenstein PR; Castro MG
    Endocrinology; 2001 Jan; 142(1):464-76. PubMed ID: 11145611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant adenovirus as vector for allergen gene therapy in a mouse model of type I allergy.
    Sudowe S; Montermann E; Steitz J; Tüting T; Knop J; Reske-Kunz AB
    Gene Ther; 2002 Jan; 9(2):147-56. PubMed ID: 11857073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
    Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
    Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene.
    van Ginkel FW; McGhee JR; Liu C; Simecka JW; Yamamoto M; Frizzell RA; Sorscher EJ; Kiyono H; Pascual DW
    J Immunol; 1997 Jul; 159(2):685-93. PubMed ID: 9218583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.
    Lee MG; Abina MA; Haddada H; Perricaudet M
    Gene Ther; 1995 Jun; 2(4):256-62. PubMed ID: 7552985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor.
    Jin HS; Park EK; Lee JM; NamKoong SE; Kim DG; Lee YJ; Jun HJ; Han BD; Bae SM; Ahn WS
    Gynecol Oncol; 2005 May; 97(2):559-67. PubMed ID: 15863160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients.
    Griscelli F; Opolon P; Saulnier P; Mami-Chouaib F; Gautier E; Echchakir H; Angevin E; Le Chevalier T; Bataille V; Squiban P; Tursz T; Escudier B
    Gene Ther; 2003 Mar; 10(5):386-95. PubMed ID: 12601393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
    Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.
    Alzuguren P; Hervas-Stubbs S; Gonzalez-Aseguinolaza G; Poutou J; Fortes P; Mancheno U; Bunuales M; Olagüe C; Razquin N; Van Rooijen N; Enguita M; Hernandez-Alcoceba R
    Liver Int; 2015 Apr; 35(4):1274-89. PubMed ID: 24754307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
    Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
    Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.